Company Number: 14026493

Analysis Date: 2025-07-20 16:39 UTC

Financial Health Assessment for INTERSTELLAR SPACE TECHNOLOGIES LTD

---

1. Financial Health Score: D

Explanation:
The company shows very limited financial resources with a negative net current assets position that worsened from £(1,871) in 2023 to £(3,166) in 2024. There are no fixed assets, indicating no investment in long-term operational capacity. The company is in its early years (incorporated 2022), and the financials resemble a start-up phase with minimal activity but increasing liabilities. This score reflects significant financial distress symptoms, limited operational scale, and potential liquidity concerns.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Fixed Assets	0	No long-term assets; may indicate no capital investment or operational infrastructure.
Current Assets	62	Extremely low liquid or short-term assets; insufficient buffer to cover liabilities.
Current Liabilities	3,228	Short-term debts or obligations significantly exceed current assets.
Net Current Assets (Working Capital)	(3,166)	Negative working capital; indicates potential liquidity crunch and inability to meet short-term obligations.
Net Assets (Equity)	(3,166)	Negative net worth; company owes more than it owns, a sign of financial weakness.
Shareholders Funds	(3,166)	Reflects accumulated losses or capital deficits.
Employees	1	Minimal headcount, typical for a micro-entity start-up.

---

3. Diagnosis: Financial Symptoms and Business Health

• Symptoms of Distress:
  The company’s balance sheet reveals a worsening liquidity problem, with current liabilities far exceeding current assets. Negative net current assets signal that the company may struggle to pay its bills on time, a classic symptom of cash flow distress. The absence of fixed assets indicates the company likely operates without significant physical or capital investment, possibly relying on outsourcing or service-based research activities.

• Start-up Phase Characteristics:
  Given the company was incorporated in April 2022 and operates in highly specialized sectors (space transport, aerospace manufacturing, research), the financials suggest a very early-stage research and development entity. The small asset base and growing liabilities may reflect initial funding rounds or early-stage operational costs not yet balanced by revenues.

• Control and Governance:
  The company is tightly controlled by a single director and majority shareholder, which can be beneficial for swift decision-making but also concentrates financial risk.

• Future Viability Concerns:
  Without external capital injections, revenue growth, or reduction of liabilities, the company risks insolvency. The micro-entity reporting thresholds and limited filing requirements mean less detailed financial transparency, which can mask operational challenges.

---

4. Recommendations: Steps to Improve Financial Wellness

1. Strengthen Liquidity Position:

   • Seek additional capital funding (equity injection or loans) to reduce the negative working capital gap.
   • Negotiate longer payment terms with creditors or reduce short-term liabilities where possible.

2. Asset Development and Investment:

   • Consider investing in fixed assets or intellectual property that can underpin future revenue streams and improve the balance sheet strength.

3. Revenue Generation Focus:

   • Accelerate commercialization of research activities or secure contracts in the space transport or aerospace sectors to improve cash inflows.

4. Cost Management:

   • Monitor and control operating expenses rigorously to avoid further erosion of equity and cash position.

5. Financial Monitoring and Reporting:

   • Implement more detailed internal financial monitoring beyond micro-entity thresholds as the business grows, to identify early warning signs.

6. Governance and Risk Management:

   • Diversify leadership or advisory support to bring additional financial or industry expertise.

---